Gelonghui, Feb. 27丨Olin Biotech (688319.SH) announced its 2023 annual results report. During the reporting period, the company achieved operating income of 496.1187 million yuan, a year-on-year decrease of 9.38%; realized net profit attributable to owners of the parent company was 17.4,104 million yuan, a year-on-year decrease of 34.49%; and realized net profit attributable to owners of the parent company after deducting non-recurring gains and losses of 3.205,500 yuan, an increase of 344.77% year on year.